Canakinumab vs Interleukin-1 Inhibitors

Interacting Drugs
Canakinumab
vs
Interleukin-1 Inhibitors
Security Level
Major, Avoid combination
Mechanism
Interleukin-1 Inhibitors: May enhance the adverse/toxic effect of Canakinumab. Whether such a combination will also alter the therapeutic response to one or both agents is unclear.
Management
Avoid combination

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Canakinumab vs Interleukin-1 Inhibitors


Other Interactions of Canakinumab

We are Developing Our database, More results coming soon.

Other Interactions of Interleukin-1 Inhibitors

We are Developing Our database, More results coming soon.